Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

LITHIUM CARBONATE

All products: general benefit

Carbolith · DIN 00461733 · 150mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Carbolith · DIN 00461733 Manufacturer: Valeant Canada Ltd.; listing date 1996-10-01 Health Canada: Marketed since 2019-06-03 · brand CARBOLITH · ATC N05AN01 LITHIUM · form Capsule · route Oral · ingredients LITHIUM CARBONATE 150 MG · company Bausch health, canada inc. · schedule Prescription
Check this DIN again · Health Canada product record

Ministry pays: $0.0667 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3414 · Verify on the e-Formulary ↗ (DIN 00461733)

Source record
DIN 00461733: Carbolith Raw flags: sec3=Y Item: 281612008; group id 512; item number 1352; lccId None; manufacturer id VAL Source form: Cap; strength: 150mg Recorded listing: General benefit Source prices (unrounded): $0.1591; ministry $0.0667 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00461733 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3414
Interchangeable products
Apo-Lithium Carbonate · DIN 02242837 · $0.0667 PMS-Lithium Carbonate · DIN 02216132 · $0.0667
Shortage status: discontinued (2025-01-20, reported by BAUSCH HEALTH, CANADA INC.); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00461733
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (28:16:12 Other Psychotropics) and how they are covered

Matched class: 28:16:12 Other Psychotropics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. No displayed product is listed as a general benefit in this extract. Check its listing requirements below. 28:16:12 Other Psychotropics

TRYPTOPHAN

· 11 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg, 750mg, 1g · Cap, Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 28:16:12
Full class listing Related classes: 28:08:04 Nonsteroidal Anti-Inflammatory Agents, 28:08:08 Opiate Agonists, 28:08:12 Opiate Partial Agonists, 28:08:92 Miscellaneous Analgesics and Antipyretics, 28:16:04 Antidepressants, 28:16:08 Tranquilizers, 28:36:08 Anticholinergic Agents, 28:36:20 Dopamine Receptor Agonists Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS LITHANE (lithium carbonate) is indicated for:  the treatment of acute manic episodes in patients with manic-depressive disorders. Maintenance therapy has been found useful in preventing or diminishing the frequency of subsequent relapses in bipolar manic-depressive patients (with a strong history of mania). 1.1 Pediatrics Pediatrics (<18 years of age): Health Canada has not authorized an indication for pediatric use (see 7.1.3 Pediatrics). 1.2 Geriatrics Evidence from clinical studies and experience suggests that use in the geriatric population is associated with differences in safety or effectiveness (see 7.1.4 Geriatrics). https://pdf.hres.ca/dpd_pm/00067512.PDF PM date: SEP 21, 2022 Source product: LITHANE; DIN 00406775; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Carbolith · DIN 00461733 Shortage status: discontinued (2025-01-20, reported by BAUSCH HEALTH, CANADA INC.); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00461733

Check this DIN again